Investing in small-cap health care companies can be tricky, with stocks that can soar or crash based on the results of a single clinical trial. However, equities.com's Small-Cap Stars, our proprietary list of small-cap companies with characteristics we've found to be most predictive of future success, isolates those companies that are best positioned to succeed.
Here are today's top performing health care Small-Cap Stars:
Chromadex Corp ($CDXC)
Chromadex Corp gained 4.81% to $1.09. The gains came on a volume of 176,017 shares against an average daily volume of 81,807 shares. Chromadex Corp has had a trading range from $2.15 to $0.71 over the last year, it has a 50-day SMA of $1.31, and a 200-day SMA of $1.48.
ChromaDex Corp through its subsidiaries, supplies phytochemical referance standards to research an array of potential attributes & reference materials, related contract services, technical consulting & proprietary ingredients.
Neuralstem Inc. ($CUR)
Neuralstem Inc. gained 3.62% to $4.01. The gains came on a volume of 877,212 shares against an average daily volume of 614,606 shares. Neuralstem Inc. has had a trading range from $4.81 to $1.55 over the last year, it has a 50-day SMA of $3.55, and a 200-day SMA of $3.49.
Neuralstem, Inc. is a biotechnology company. It is engaged in the development and commercialization of treatments for central nervous system disease based on transplanting human neural stem cells and the use of small molecule drugs.
Horizon Pharma Inc. ($HZNP)
Horizon Pharma Inc. gained 2.63% to $10.16. The gains came on a volume of 1,992,890 shares against an average daily volume of 2,414,639 shares. Horizon Pharma Inc. has had a trading range from $18.30 to $2.46 over the last year, it has a 50-day SMA of $12.47, and a 200-day SMA of $11.49.
Horizon Pharma Inc is a specialty pharmaceutical company. It has developed and is commercializing DUEXIS, VIMOVO and RAYOS/LODOTRA, each of which targets unmet therapeutic needs in arthritis, pain and inflammatory diseases.
Idera Pharmaceuticals Inc. ($IDRA)
Idera Pharmaceuticals Inc. gained 1.39% to $2.92. The gains came on a volume of 713,042 shares against an average daily volume of 939,582 shares. Idera Pharmaceuticals Inc. has had a trading range from $6.87 to $1.52 over the last year, it has a 50-day SMA of $2.75, and a 200-day SMA of $3.51.
Idera Pharmaceuticals, Inc. is a clinical stage biotechnology company engaged in the discovery and development of novel synthetic DNA- and RNA- based drug candidates.
Aradigm Corp. ($ARDM)
Aradigm Corp. gained 1.34% to $9.08. The gains came on a volume of 5,230 shares against an average daily volume of 10,153 shares. Aradigm Corp. has had a trading range from $15.00 to $7.00 over the last year, it has a 50-day SMA of $8.72, and a 200-day SMA of $0.00.
Aradigm Corp is a specialty pharmaceutical company engaged in the development and commercialization of drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases.
Equities.com's Health Care Small-Cap Stars - Helping You Build a Healthier Portfolio
No one can predict precisely which potential treatments will fly through their clinical trials and which will stumble along the way. At least, if someone can, they're undoubtedly spectacularly wealthy right now. But, while the science is clearly the most important factor for the success of a small-cap biotech company, it's not the only one.
Equities.com's Small-Cap Stars system uses a complicated statistical regression to determine which fundamental factors previous success stories had in common and then identifies those present health care small caps that share those traits. For health care companies, we found that a high enterprise value, a strong value line beta, and a high rate of reinvestment were among the most important qualities in predicting the potential success of a company.
All data provided by quotemedia and was accurate as of 4:30 pm ET.